Crohn's Disease

Takeda backs biomarker trial for Crohn's prevention
Pharmaphorum
Wed, 01/22/25 - 11:18 am
Takeda
biomarkers
Crohn's Disease
Lilly's Omvoh scores second IBD win with FDA nod in Crohn's
First Word Pharma
Wed, 01/15/25 - 11:50 pm
Eli Lilly
Omvoh
IBD
FDA
Crohn's Disease
Dueling IL-23 data drop as Lilly, J&J await FDA decisions in Crohn's
First Word Pharma
Mon, 10/28/24 - 06:24 pm
Eli Lilly
JNJ
Crohn's Disease
FDA
clinical trials
Tremfya
Omvoh
On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study
Fierce Pharma
Tue, 10/15/24 - 10:15 am
Eli Lilly
Crohn's Disease
Omvoh
clinical trials
JNJ
Stelara
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Medical Marketing and Media
Mon, 10/7/24 - 09:52 pm
AbbVie
Skyrizi
Crohn's Disease
psoriatic arthritis
Ventyx Ends Development of TYK2 Inhibitor After Phase II Flop in Crohn’s Disease
BioSpace
Tue, 07/30/24 - 11:34 am
Ventyx Biosciences
VTX958
Crohn's Disease
J&J Positions Tremfya as Stelara Successor with Strong Head-to-Head Data
BioSpace
Wed, 05/22/24 - 11:33 am
JNJ
Tremfya
Stelara
Crohn's Disease
Bristol Myers' bowel disease drug fails to meet main goal in late-stage study
Reuters
Thu, 03/28/24 - 05:07 pm
Bristol Myers Squibb
Crohn's Disease
clinical trials
ozanimod
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Motley Fool
Sun, 10/29/23 - 08:44 pm
Roche
Eli Lilly
Pfizer
IBD
ulcerative colitis
Crohn's Disease
mirikizumab
FDA approves Celltrion’s subcutaneous Remicade biosimilar for IBD
Pharm
Mon, 10/23/23 - 05:20 pm
Celltrio
Zymfentra
ulcerative colitis
Crohn's Disease
biosimilars
Remicade
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication
Fierce Pharma
Thu, 10/19/23 - 10:07 am
Takeda
Crohn's Disease
Alofisel
clinical trials
stem cells
Janssen’s Tremfya maintains three years of remission in Phase II Crohn’s disease trial
Clinical Trials Arena
Tue, 10/17/23 - 11:45 am
JNJ
Janssen
clinical trials
Crohn's Disease
Tremfya
AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease
Fierce Pharma
Mon, 10/16/23 - 11:50 am
AbbVie
Akyrizi
JNJ
Stelara
Crohn's Disease
Lilly’s Mirikizumab Shows Long-Term Remission in Phase III Crohn’s Trial
BioSpace
Thu, 10/12/23 - 05:22 pm
Eli Lilly
mirikizumab
Crohn's Disease
FDA
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
Wed, 09/13/23 - 11:36 am
AbbVie
Skyrizi
JNJ
Stelara
Crohn's Disease
clinical trials
AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report
BioSpace
Fri, 09/8/23 - 11:29 am
AbbVie
Humira
biosimilars
Crohn's Disease
Roche in Talks to Buy Stomach Drug from Roivant for $7B: Report
BioSpace
Fri, 07/14/23 - 11:56 am
Roche
Roivant
ulcerative colitis
Crohn's Disease
M&A
AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease
Fierce Pharma
Thu, 05/18/23 - 08:36 pm
AbbVie
FDA
Rinvoq
Crohn's Disease
Humira
Amgen invests in TScan’s TargetScan platform for Crohn’s Disease breakthroughs
Medical Marketing and Media
Tue, 05/9/23 - 11:24 pm
Amgen
TScan
TargetScan
Crohn's Disease
Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor
Fierce Pharma
Fri, 02/10/23 - 11:09 am
Galapagos
FDA
filgotinib
Crohn's Disease
clinical trials
Jyseleca

Pages